Dravet syndrome treatment market

Dravet Syndrome Treatment MarketINDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2016–2024

REPORT DESCRIPTION Dravet Syndrome Treatment Market: Overview Dravet syndrome (DS), also known as epilepsy with polymorphic seizures and polymorphic epilepsy in infancy (PMEI), is a severe and rare genetic dysfunction of the brain (epileptic encephalopathy). It usually begins in first year of life and remains throughout lifetime. Children suffering from dravet syndrome suffer from different type of seizures namely, myoclonic seizures, tonic-clonic seizures, absence seizures, atypical absence seizures, atonic seizures, focal aware or impaired awareness seizures (previously called partial seizures), and status epilepticus. Generally, combination of drugs are prescribed for the treatment of Dravet syndrome. Anticonvulsants such as stiripentol, topiramate, and Valproic acid are the most commonly used drugs for treatment of seizures and Dravet syndrome. In cases where intensity of seizures are not reduced by medication, certain devices are used to treat Dravet syndrome. Vagal nerve stimulation device is one such device, which delivers electrical impulses to the vagus nerve.

REPORT DESCRIPTION Dravet Syndrome Treatment Market: Taxonomy North America is expected to a hold dominant position in the global Dravet syndrome treatment market, owing to increasing initiatives and funding by various organizations to support the development of new treatment for Dravet syndrome. For instances, in 2017, The Dravet Syndrome Foundation—a U.S.-based non-profit organization dedicated to funding the highest caliber research on Dravet syndrome —funded a total amount of US$ 3,600,000 for the development of novel treatment methods for Dravet syndrome. In 2011, Dravet Syndrome Foundation granted an undisclosed amount to U.S.-based OPKO Health, Inc., to support the company's efforts to develop potential therapeutic agents for the treatment of Dravet syndrome. The market in Europe is expected to exhibit significant growth in the Dravet syndrome treatment market, owing to increasing research and development activities being adopted by key players present in the region. Get The Holistic SAMPLE With TOC@

REPORT DESCRIPTION Dravet Syndrome Treatment Market : Key Players ● ● ● ● ● ● ● ● ●

Epygenix Therapeutics, Inc. Ovid Therapeutics GW Pharmaceuticals Plc. Takeda Pharmaceutical Company Ltd Zogenix, Inc OPKO Health Inc. Biocodex S.A. Biscayne Neurotherapeutics, Inc. PTC Therapeutics, Inc.

Ask For Sample Copy@ https://www.coherentmarketinsights.com/insight/request-sample/1548

ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.

CUSTOMIZED RESEARCH CONSULT STUDIES

SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES

ABOUT CMI SECTOR COVERAGE

BIOTECHNOLOGY

CLINICAL DIAGNOSTIC

MEDICAL DEVICES

MEDICAL IMAGING

OUR CLIENTS        

Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies Universities and Business Schools.

HEALTHCARE IT

PHARMACEUTICAL

ABOUT COHERENT MARKET INSIGHTS

KEY STATS

RESEARCH SOLUTIONS

FEASIBILITY STUDIES

GLOBAL REPORTS

100+ Insights Published Per Year

150+ Consulting Projects Till Date

125+

COUNTRY ANALYSIS

CONSULT PROJECTS

SURVEY RESEAR CH

EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT

Clients Worldwide Per Year

110+

TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.

THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 ÂŠ Coherent market Insights. All Rights Reserved

Turn static files into dynamic content formats.

Create a flipbook